Guay DR and Craft JC |
Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295810
|
Sader HS et al. |
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. |
1993 Aug-Sep |
Diagn. Microbiol. Infect. Dis. |
pmid:8243035
|
Miller CA |
Infections, resistant microbes, and older adults. |
1993 Jan-Feb |
Geriatr Nurs |
pmid:8383085
|
Ritchie DJ et al. |
In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. |
1993 Jan-Feb |
Clin Ther |
pmid:8458040
|
Albani F et al. |
Clarithromycin-carbamazepine interaction: a case report. |
1993 Jan-Feb |
Epilepsia |
pmid:8422851
|
Adam D |
Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis. |
1993 Jul-Aug |
Infection |
pmid:8225636
|
Coles SJ et al. |
A comparative study of clarithromycin and amoxycillin suspensions in the treatment of pediatric patients with acute otitis media. |
1993 Jul-Aug |
Infection |
pmid:8225637
|
Ohmori S et al. |
Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats. |
1993 Mar-Apr |
Drug Metab. Dispos. |
pmid:8097709
|
Wallace RJ et al. |
Drug intolerance to high-dose clarithromycin among elderly patients. |
1993 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:8477575
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Wüst J and Hardegger U |
Penetration of clarithromycin into human saliva. |
1993 Sep-Oct |
Chemotherapy |
pmid:8370320
|
Ploy MC et al. |
[Antibacterial activity of clarithromycin and its hydroxylated derivative and two other macrolides against thirty strains of Streptococcus pneumoniae]. |
1994 |
Pathol. Biol. |
pmid:7824300
|
Gevaudan MJ et al. |
[Evaluation of the extra- and intracellular activity of clarithromycin against Mycobacterium chelonae]. |
1994 |
Pathol. Biol. |
pmid:7824305
|
Rolinson GN |
A clarithromycin sensitivity survey. |
1994 |
J. Antimicrob. Chemother. |
pmid:7829420
|
Durodie J and Slocombe B |
A clarithromycin sensitivity survey. |
1994 |
J. Antimicrob. Chemother. |
pmid:7829421
|
Sano M et al. |
[Inhibition of biofilm formation by clarithromycin (CAM) in an experimental model of complicated bladder infection--in vitro study using automated simulation of urinary antimicrobial concentration]. |
1994 |
Kansenshogaku Zasshi |
pmid:7829898
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Guelar A et al. |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. |
1994 |
Enferm. Infecc. Microbiol. Clin. |
pmid:8011719
|
Aspin MM et al. |
Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. |
1994 |
J. Pediatr. |
pmid:8021763
|
Chaisson RE et al. |
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. |
1994 |
Ann. Intern. Med. |
pmid:7978715
|
Goldberger M and Masur H |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems. |
1994 |
Ann. Intern. Med. |
pmid:7978725
|
Ohgaki N |
Bacterial biofilm in chronic airway infection. |
1994 |
Kansenshogaku Zasshi |
pmid:8138670
|
Yasuda H et al. |
Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141568
|
|
Uveitis associated with rifabutin therapy. |
1994 |
MMWR Morb. Mortal. Wkly. Rep. |
pmid:8072478
|
Sano M et al. |
[Adaptation study for biofilm of the urinary tract via highly complicated bladder model (biofilm model of the urinary tract)--experimental study using automatic simulator of the urinary antimicrobial agent concentration]. |
1994 |
Kansenshogaku Zasshi |
pmid:8089557
|
|
AIDS patients have a new weapon against MAC infection. |
1994 |
RN |
pmid:8128150
|
Fujii K et al. |
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067748
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Goldman RC et al. |
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979278
|
Lazard T et al. |
Chloroquine does not enhance the activity of clarithromycin against multiplication of Mycobacterium avium within human macrophages. |
1994 |
Tuber. Lung Dis. |
pmid:7949074
|
Roblin PM et al. |
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979292
|
Inderlied CB et al. |
Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986017
|
Bermudez LE et al. |
Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986018
|
al-Assi MT et al. |
Clarithromycin-amoxycillin therapy for Helicobacter pylori infection. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:7986970
|
Neri M et al. |
Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:7986974
|
|
[Recent advances in macrolide antibiotics: focused on clarithromycin. Discussion]. |
1994 |
Jpn J Antibiot |
pmid:7990251
|
Wallace RJ et al. |
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. |
1994 |
Am. J. Respir. Crit. Care Med. |
pmid:8173775
|
Bermudez LE et al. |
Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695252
|
Mor N et al. |
Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695255
|
Calì G et al. |
[Clarithromycin in the treatment of oral infections]. |
1994 |
Minerva Stomatol |
pmid:7700226
|
Reed PI |
The ECP-IM intervention study. |
1994 |
Eur. J. Cancer Prev. |
pmid:7735056
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Jones RN et al. |
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards. |
1994 |
Diagn. Microbiol. Infect. Dis. |
pmid:7924221
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
Rapp RP et al. |
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. |
1994 |
Ann Pharmacother |
pmid:7849341
|
Yamada S et al. |
[A child with iritis due to Chlamydia pneumoniae infection]. |
1994 |
Kansenshogaku Zasshi |
pmid:7876679
|